Femke Waanders

2.2k total citations
47 papers, 1.6k citations indexed

About

Femke Waanders is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Femke Waanders has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Nephrology, 10 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Nutrition and Dietetics. Recurrent topics in Femke Waanders's work include Chronic Kidney Disease and Diabetes (11 papers), Parathyroid Disorders and Treatments (8 papers) and Advanced Glycation End Products research (7 papers). Femke Waanders is often cited by papers focused on Chronic Kidney Disease and Diabetes (11 papers), Parathyroid Disorders and Treatments (8 papers) and Advanced Glycation End Products research (7 papers). Femke Waanders collaborates with scholars based in Netherlands, United States and Italy. Femke Waanders's co-authors include Gerjan Navis, Liffert Vogt, Harry van Goor, Dick de Zeeuw, Frans Boomsma, Gozewijn D. Laverman, Maartje C.J. Slagman, Bakhtawar K. Mahmoodi, Min Ki ten Kate and Jan‐Leendert P. Brouwer and has published in prestigious journals such as Circulation, PLoS ONE and Kidney International.

In The Last Decade

Femke Waanders

46 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Femke Waanders Netherlands 20 794 500 335 285 280 47 1.6k
James Ehrlich United States 17 704 0.9× 552 1.1× 307 0.9× 489 1.7× 210 0.8× 23 2.0k
Jay Garg United States 15 652 0.8× 488 1.0× 185 0.6× 319 1.1× 205 0.7× 42 2.6k
Rachel M. Holden Canada 25 1.0k 1.3× 435 0.9× 662 2.0× 144 0.5× 358 1.3× 85 2.1k
M. Temmar France 8 983 1.2× 347 0.7× 151 0.5× 169 0.6× 259 0.9× 9 1.7k
Hilmi Umut Ünal Türkiye 20 457 0.6× 276 0.6× 148 0.4× 184 0.6× 155 0.6× 42 1.4k
Angel de Francisco Spain 15 610 0.8× 166 0.3× 170 0.5× 225 0.8× 147 0.5× 19 1.7k
N. El Esper France 17 649 0.8× 298 0.6× 178 0.5× 212 0.7× 288 1.0× 47 1.2k
Jacek Małyszko Poland 27 956 1.2× 369 0.7× 100 0.3× 177 0.6× 364 1.3× 163 2.6k
Maura Ravera Italy 25 641 0.8× 1.1k 2.2× 170 0.5× 288 1.0× 278 1.0× 61 1.7k
Mhairi K. Sigrist Canada 19 1.2k 1.6× 492 1.0× 217 0.6× 126 0.4× 260 0.9× 29 1.9k

Countries citing papers authored by Femke Waanders

Since Specialization
Citations

This map shows the geographic impact of Femke Waanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Femke Waanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Femke Waanders more than expected).

Fields of papers citing papers by Femke Waanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Femke Waanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Femke Waanders. The network helps show where Femke Waanders may publish in the future.

Co-authorship network of co-authors of Femke Waanders

This figure shows the co-authorship network connecting the top 25 collaborators of Femke Waanders. A scholar is included among the top collaborators of Femke Waanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Femke Waanders. Femke Waanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Waanders, Femke, et al.. (2021). Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD. Clinical Kidney Journal. 14(10). 2170–2176. 2 indexed citations
3.
Waanders, Femke, Robin P.F. Dullaart, Michel J. Vos, et al.. (2019). Hypomagnesaemia and its determinants in a contemporary primary care cohort of persons with type 2 diabetes. Endocrine. 67(1). 80–86. 16 indexed citations
4.
Sidorenkov, Grigory, Frans J. van Ittersum, Femke Waanders, et al.. (2019). Prescribing quality in secondary care patients with different stages of chronic kidney disease: a retrospective study in the Netherlands. BMJ Open. 9(7). e025784–e025784. 4 indexed citations
5.
Gant, Christina M., Gozewijn D. Laverman, Liffert Vogt, et al.. (2017). Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels. BMC Nephrology. 18(1). 370–370. 14 indexed citations
6.
Frenay, Anne-Roos S., Saleh Yazdani, Miriam Boersema, et al.. (2015). Incomplete Restoration of Angiotensin II - Induced Renal Extracellular Matrix Deposition and Inflammation Despite Complete Functional Recovery in Rats. PLoS ONE. 10(6). e0129732–e0129732. 5 indexed citations
7.
Waanders, Femke, et al.. (2014). Quiz Page May 2014. American Journal of Kidney Diseases. 63(5). A21–A24. 3 indexed citations
8.
Waanders, Femke, et al.. (2014). Volume control in treatment-resistant congestive heart failure: role for peritoneal dialysis. Heart Failure Reviews. 19(6). 709–716. 5 indexed citations
9.
Humalda, Jelmer K., Hiddo J.L. Heerspink, Arjan J. Kwakernaak, et al.. (2014). Fibroblast Growth Factor 23 and the Antiproteinuric Response to Dietary Sodium Restriction During Renin-Angiotensin-Aldosterone System Blockade. American Journal of Kidney Diseases. 65(2). 259–266. 25 indexed citations
10.
Kwakernaak, Arjan J., Femke Waanders, Maartje C.J. Slagman, et al.. (2013). Sodium restriction on top of renin–angiotensin–aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients. Journal of Hypertension. 31(12). 2425–2432. 17 indexed citations
11.
Kwakernaak, Arjan J., Gilles Lambert, Maartje C.J. Slagman, et al.. (2012). Proprotein convertase subtilisin–kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment. Atherosclerosis. 226(2). 459–465. 50 indexed citations
12.
Mahmoodi, Bakhtawar K., André B. Mulder, Femke Waanders, et al.. (2011). The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria. Journal of Thrombosis and Haemostasis. 9(12). 2416–2423. 11 indexed citations
13.
Peters, Hilde P.E., Femke Waanders, Esther Meijer, et al.. (2011). High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrology Dialysis Transplantation. 26(11). 3581–3588. 59 indexed citations
14.
Krenning, Guido, Patricia Y. W. Dankers, Femke Waanders, et al.. (2009). Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. American Journal of Physiology-Renal Physiology. 296(6). F1314–F1322. 61 indexed citations
15.
Waanders, Femke, Mirjan M. van Timmeren, Coen A. Stegeman, Stephan J. L. Bakker, & Harry van Goor. (2009). Kidney injury molecule‐1 in renal disease. The Journal of Pathology. 220(1). 7–16. 115 indexed citations
16.
Waanders, Femke, Andrea B. Kramer, Harry van Goor, et al.. (2009). Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species. Nephrology Dialysis Transplantation. 24(9). 2637–2645. 56 indexed citations
17.
Waanders, Femke, Mark Walther Boer, André Zandvoort, et al.. (2009). Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats. American Journal of Physiology-Renal Physiology. 296(5). F1072–F1079. 27 indexed citations
18.
Vogt, Liffert, Femke Waanders, Frans Boomsma, Dick de Zeeuw, & Gerjan Navis. (2008). Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan. Journal of the American Society of Nephrology. 19(5). 999–1007. 261 indexed citations
19.
Waanders, Femke, et al.. (2005). Mesangial accumulation of GA-pyridine, a novel glycolaldehyde-derived AGE, in human renal disease. Kidney International. 68(2). 595–602. 13 indexed citations
20.
Waanders, Femke, John Baynes, Suzanne R. Thorpe, et al.. (2005). Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats. Nephrology Dialysis Transplantation. 20(10). 2060–2070. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Ehrlich Breakdown of academic impact, for papers by Jay Garg Breakdown of academic impact, for papers by Rachel M. Holden Breakdown of academic impact, for papers by M. Temmar Breakdown of academic impact, for papers by Hilmi Umut Ünal Breakdown of academic impact, for papers by Angel de Francisco Breakdown of academic impact, for papers by N. El Esper Breakdown of academic impact, for papers by Jacek Małyszko Breakdown of academic impact, for papers by Maura Ravera Breakdown of academic impact, for papers by Mhairi K. Sigrist
Rankless by CCL
2026